Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on ...
Circle’s venture capital arm has joined forces with crypto infrastructure firm Crossmint to expand the USDC stablecoin across ...
The line between fashion and design is disappearing. Silas Adler’s Other Circle brings together artists, chefs, designers and ...
Iqbal Ansari, one of the main litigants in Ayodhya dispute case, said his advice was "to use the land allotted for mosque to ...